AKSA vs MEDTR Comparison
Price, market cap, valuation, profitability and leverage metrics of AKSA and MEDTR side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | AKSA | MEDTR | Sector median |
|---|---|---|---|
| Last price (TL) | 9.91 | 17.86 | 10.81 |
| Daily change | −0.80% | 4.57% | −0.30% |
| Market cap | TRY 38.5B | TRY 2.1B | TRY 2.9B |
| P/E | 5.97 | 58.48 | 11.94 |
| P/B | 1.06 | 0.61 | 0.80 |
| Dividend yield | 5.23% | 0.66% | 1.06% |
| Return on equity | 19.47% | 1.14% | 1.14% |
| Free float | 29.13% | 20.21% | 36.14% |
Popular Comparisons
Related Pages
About the AKSA vs MEDTR Comparison
Price, market cap, valuation multiples, profitability and leverage of AKSA (Aksa) and MEDTR (Meditera Tibbi Malzeme) side by side as of Nov 2, 2026, 18:15. Of the 15 metrics compared, AKSA leads in 7 and MEDTR leads in 8.
Highlights: Daily change: MEDTR leads (4.57% vs −0.80%). Market cap: AKSA leads (TRY 38.5B vs TRY 2.1B). P/E: AKSA leads (5.97 vs 58.48). P/B: MEDTR leads (0.61 vs 1.06). EV/EBITDA: MEDTR leads (6.47 vs 8.75). EV/Sales: MEDTR leads (1.16 vs 2.73). Dividend yield: AKSA leads (5.23% vs 0.66%). Gross margin: MEDTR leads (33.71% vs 14.83%).
Frequently Asked Questions
Is AKSA or MEDTR cheaper?
By P/E, AKSA is cheaper (5.97 vs 58.48); by P/B, MEDTR trades at the lower multiple (1.06 vs 0.61).
Which is more profitable, AKSA or MEDTR?
Annual net margin is 17.92% for AKSA and 1.35% for MEDTR; return on equity is 19.47% for AKSA and 1.14% for MEDTR.
Which is more leveraged, AKSA or MEDTR?
The leverage ratio is 51.59 for AKSA and 15.79 for MEDTR; net debt/EBITDA is 3.02 for AKSA and — for MEDTR. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.